Jacobs Cindy's most recent trade in Achieve Life Sciences Inc. was a trade of 130,000 Performance Restricted Stock Unit (PRSU) done . Disclosure was reported to the exchange on Jan. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 130,000 | 130,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 3.67 per share. | 16 Aug 2024 | 2,660 | 33,214 (0%) | 0% | 3.7 | 9,762 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 16,250 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2024 | 16,250 | 34,511 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.51 per share. | 19 Apr 2024 | 3,957 | 30,554 (0%) | 0% | 4.5 | 17,846 | Common Stock |
| Achieve Life Sciences Inc | Jacobs Cindy | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 84,000 | 84,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 2,500 | 18,870 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 2,500 | 0 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.29 per share. | 28 Apr 2023 | 609 | 18,261 (0%) | 0% | 8.3 | 5,049 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.80 per share. | 21 Apr 2023 | 3,811 | 16,370 (0%) | 0% | 6.8 | 25,915 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 60,000 | 60,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 4.37 per share. | 16 Aug 2022 | 1,817 | 3,931 (0%) | 0% | 4.4 | 7,940 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 2,500 | 2,723 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 2,500 | 2,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.43 per share. | 28 Apr 2022 | 609 | 2,114 (0%) | 0% | 7.4 | 4,525 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 32,500 | 32,500 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 32,500 | 32,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 68 | 244 (0%) | 0% | 0 | Common Stock | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 68 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.81 per share. | 17 Aug 2021 | 21 | 223 (0%) | 0% | 6.8 | 143 | Common Stock |
| Achieve Life Sciences Inc | Cindy Jacobs | President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Cindy Jacobs | President & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 5,000 | 5,000 | - | - | Performance Restricted Stock Unit (PRSU) |